AI assistant
Novonesis AS Director's Dealing 2017
3377_rns_2017-01-23_45a8bcf2-3ca8-4736-b7a5-70a2e005c95d.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Trading by management and of close relations to management
January 23, 2017
Company announcement No. 3
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation), Novozymes reports the following transactions under ISIN DK0060336014, Novozymes B shares under the symbol NZYM B
| Name | Anders Lund |
|---|---|
| Relation /category of close relation | EVP Household Care & Technical |
| Trading date | January 20, 2017 |
| Market | Nasdaq OMX Copenhagen A/S |
| Nature of transaction and type of financial instrument | Sale of shares |
| Volume of transaction buy (+) / sell (-) | -14,477 |
| Value of transaction (DKK) | 3,561,342 |
Contact information
Martin Riise
+45 3077 0738
Klaus Sindahl
+45 5363 0134
Nicolai Agerskov Kobborg
+45 3077 1348
About Novozymes
Novozymes is the world leader in biological solutions. Together with customers, partners and the global community, we improve industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com
Novozymes A/S CVR number: 55 00 71 27 LEI: 52990076WNZXD2R3JW38
Rethink Tomorrow
Novozymes A/S
Krogshoejvej 36
2880 Bagsvaerd
Denmark
Phone: +45 4446 0000
novozymes